These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24591109)

  • 1. Tumor vasculature targeting: a generally applicable approach for functionalized nanomaterials.
    Chen F; Cai W
    Small; 2014 May; 10(10):1887-93. PubMed ID: 24591109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
    Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
    Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles modified with vasculature-homing peptides for targeted cancer therapy and angiogenesis imaging.
    Seyyednia E; Oroojalian F; Baradaran B; Mojarrad JS; Mokhtarzadeh A; Valizadeh H
    J Control Release; 2021 Oct; 338():367-393. PubMed ID: 34461174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart Nanotherapeutic Targeting of Tumor Vasculature.
    Li Z; Di C; Li S; Yang X; Nie G
    Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer.
    Rajabi M; Adeyeye M; Mousa SA
    Curr Med Chem; 2019; 26(30):5664-5683. PubMed ID: 31250748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
    Greish K
    J Drug Target; 2007; 15(7-8):457-64. PubMed ID: 17671892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Targeting and Positron Emission Tomography Imaging of Tumor with Intrinsically Radioactive Metal-Organic Frameworks Nanomaterials.
    Chen D; Yang D; Dougherty CA; Lu W; Wu H; He X; Cai T; Van Dort ME; Ross BD; Hong H
    ACS Nano; 2017 Apr; 11(4):4315-4327. PubMed ID: 28345871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles' interactions with vasculature in diseases.
    Tee JK; Yip LX; Tan ES; Santitewagun S; Prasath A; Ke PC; Ho HK; Leong DT
    Chem Soc Rev; 2019 Oct; 48(21):5381-5407. PubMed ID: 31495856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targeting of the tumor vasculature.
    Tozer GM; Bicknell R
    Semin Radiat Oncol; 2004 Jul; 14(3):222-32. PubMed ID: 15254865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of integrins as biomarkers for tumor angiogenesis.
    Cai W; Niu G; Chen X
    Curr Pharm Des; 2008; 14(28):2943-73. PubMed ID: 18991712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality molecular imaging of tumor angiogenesis.
    Cai W; Chen X
    J Nucl Med; 2008 Jun; 49 Suppl 2():113S-28S. PubMed ID: 18523069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination drug delivery via multilamellar vesicles enables targeting of tumor cells and tumor vasculature.
    Liu Y; Kim YJ; Siriwon N; Rohrs JA; Yu Z; Wanga P
    Biotechnol Bioeng; 2018 Jun; 115(6):1403-1415. PubMed ID: 29457630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour vasculature targeting agents in hybrid/conjugate drugs.
    Prokopiou EM; Ryder SA; Walsh JJ
    Angiogenesis; 2013 Jul; 16(3):503-24. PubMed ID: 23543223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New strategies in anti-vascular cancer therapy.
    Bloemendal HJ; Logtenberg T; Voest EE
    Eur J Clin Invest; 1999 Sep; 29(9):802-9. PubMed ID: 10469169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General synthesis of silica-based yolk/shell hybrid nanomaterials and
    Chen F; Goel S; Shi S; Barnhart TE; Lan X; Cai W
    Nano Res; 2018 Sep; 11(9):4890-4904. PubMed ID: 30410684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography imaging using radiolabeled inorganic nanomaterials.
    Sun X; Cai W; Chen X
    Acc Chem Res; 2015 Feb; 48(2):286-94. PubMed ID: 25635467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the tumor vascular compartment to improve conventional cancer therapy.
    Feron O
    Trends Pharmacol Sci; 2004 Oct; 25(10):536-42. PubMed ID: 15380938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis.
    Lim EH; Danthi N; Bednarski M; Li KC
    Nanomedicine; 2005 Jun; 1(2):110-4. PubMed ID: 17292065
    [No Abstract]   [Full Text] [Related]  

  • 19. Nanoparticle-mediated delivery of anticancer agents to tumor angiogenic vessels.
    Asai T
    Biol Pharm Bull; 2012; 35(11):1855-61. PubMed ID: 23123455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnological strategies for therapeutic targeting of tumor vasculature.
    Ding Y; Li S; Nie G
    Nanomedicine (Lond); 2013 Jul; 8(7):1209-22. PubMed ID: 23837858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.